Source: http://www.google.com/patents/US20040138745?dq=6031454
Timestamp: 2016-02-05 22:46:38
Document Index: 432552152

Matched Legal Cases: ['art 100', 'art 200', 'art 300', 'art 100', 'art 200', 'art 300']

Patent US20040138745 - Methods and devices for heart valve treatments - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inPatentsThe present invention is a group of medical devices designed to improve heart valve function. The medical devices may be used individually, or in combination to supplement damaged valves, replace damaged valves, or improve damaged valves function. The medical devices include leaflet retainers, a neo-annulus,...http://www.google.com/patents/US20040138745?utm_source=gb-gplus-sharePatent US20040138745 - Methods and devices for heart valve treatmentsAdvanced Patent SearchPublication numberUS20040138745 A1Publication typeApplicationApplication numberUS 10/695,433Publication dateJul 15, 2004Filing dateOct 28, 2003Priority dateOct 1, 2001Also published asCA2455444A1, CA2462254A1, CN1610529A, CN100333704C, CN101108144A, EP1434542A2, US7291168, US20060106456, US20080140190, WO2003028558A2, WO2003028558A8Publication number10695433, 695433, US 2004/0138745 A1, US 2004/138745 A1, US 20040138745 A1, US 20040138745A1, US 2004138745 A1, US 2004138745A1, US-A1-20040138745, US-A1-2004138745, US2004/0138745A1, US2004/138745A1, US20040138745 A1, US20040138745A1, US2004138745 A1, US2004138745A1InventorsJohn Macoviak, Robert Chang, Timothy Machold, David Rahdert, Rick SossOriginal AssigneeAmple Medical, Inc.Export CitationBiBTeX, EndNote, RefManPatent Citations (31), Referenced by (149), Classifications (29), Legal Events (10) External Links: USPTO, USPTO Assignment, EspacenetMethods and devices for heart valve treatments
US 20040138745 A1Abstract
The present invention is a group of medical devices designed to improve heart valve function. The medical devices may be used individually, or in combination to supplement damaged valves, replace damaged valves, or improve damaged valves function. The medical devices include leaflet retainers, a neo-annulus, neo-leaflet, and a framework. In addition, the present invention is novel methods for surgically treating heart valves. Images(31) Claims(49)
We claim: 1. A medical device comprising: a base member having a shape such that it tracks the circumference of a native heart valve annulus; and a bridge member extending from the base member over the heart valve orifice, and supported by the base member. 2. The medical device of claim 1, further comprising a spanning material, the spanning material suspended from the bridge member, and adjacent portions of the base member, wherein the spanning material is coupled to the bridge member and adjacent portions of the base member by an attachment means. 3. The medical device of claim 1, wherein the bridge member is manufactured from a super-elastic material. 4. The medical device of claim 1, wherein the base member is sized to change the shape of the native valve annulus when attached to the native valve annulus. 5. The medical device of claim 1, wherein the spanning material is from a group consisting of Nitinol, Dacron fabric, Polytetrafluoroethylene, Silicone, Polyurethane, human pericardium, and animal pericardium. 6. The medical device of claim 1, wherein the attachment means is selected from a group consisting of sewing, gluing, welding, and wrapping the spanning material around itself. 7. The medical device of claim 1, further comprising a framework coupled to the base member and rising from the base member and into the surrounding heart chamber, the reactive forces of the heart on the framework transmitted through the framework and into the annulus retainer. 8. The medical device of claim 7, wherein the framework is shaped to avoid the pulmonary veins. 9. A medical device comprising: a base member shaped such that it tracks the circumference of a native heart valve annulus, a set of bridge members extending from the base member over the heart valve orifice, and supported by the base member, and a spanning material suspended from each bridge member, and adjacent portions of the base member, wherein the spanning material is coupled to the bridge member and adjacent portions of the base member by an attachment means. 10. The medical device of claim 9, wherein the bridge members are manufactured from a super-elastic material. 11. The medical device of claim 9, wherein the base member is sized to change the shape of the native valve annulus when attached to the native valve annulus. 12. The medical device of claim 9, wherein the spanning material is from a group consisting of Nitinol, Dacron fabric, Polytetrafluoroethylene, Silicone, Polyurethane, human pericardium, and animal pericardium. 13. The medical device of claim 9, wherein the attachment means is selected from a group consisting of sewing, gluing, welding, and wrapping the spanning material around itself 14. The medical device of claim 9, further comprising a framework coupled to the base member and rising from the base member and into the surrounding heart chamber, the reactive forces of the heart on the framework transmitted through the framework and into the annulus retainer. 15. The medical device of claim 14, wherein the framework is shaped to avoid the pulmonary veins. 16. The medical device of claim 9, further including clips, the clips protrude from the base member and press into the ventricular side of the annulus. 17. A medical device comprising: a semicircular annular ring, and a spanning material, wherein the spanning material is coupled to the semicircular annular ring. 18. The medical device of claim 17, wherein the semicircular annular ring is manufactured from a super-elastic material. 19. The medical device of claim 17, wherein the semicircular annular ring is sized to change the shape of the native valve annulus when attached to the native valve annulus. 20. The medical device of claim 17, wherein the spanning material is from a group consisting of Nitinol, Dacron fabric, Polytetrafluoroethylene, Silicone, Polyurethane, human pericardium, and animal pericardium. 21. A medical device comprising: a circular annular ring, and a spanning material, wherein the spanning material is coupled to the circular annular ring such that the spanning material spans a portion of the circular annular ring to function as a coaptation surface for an functioning native leaflet. 22. The medical device of claim 21, wherein the circular annular ring is manufactured from a super-elastic material. 23. The medical device of claim 21, wherein the circular annular ring is sized to change the shape of the native valve annulus when attached to the native valve annulus. 24. The medical device of claim 21, wherein the spanning material is from a group consisting of Nitinol, Dacron fabric, Polytetrafluoroethylene, Silicone, Polyurethane, human pericardium, and animal pericardium. 25. A medical device comprising: an outer hoop, an inner hoop, and struts that radiate between the inner and outer hoops, wherein the struts are coupled to the outer and inner hoops. 26. The medical device of claim 25, wherein the medical device is manufactured from a super-elastic material. 27. The medical device of claim 25, wherein the medical device is sized to change the shape of the native valve annulus when attached to the native valve annulus. 28. A medical device, comprising: a wire shaped to encircle the annulus of a heart valve, and radiate along the plane of the annulus both toward and away from the center of the valve orifice in a rhythmic pattern that enables the wire to contact both the valve leaflets and the adjacent heart walls. 29. The medical device of claim 28, wherein the wire is manufactured from a super-elastic material. 30. The medical device of claim 28, wherein the wire may be deployed from an intravascular catheter device. 31. A medical device, comprising: a wire shaped to encircle the annulus of a heart valve, and radiate along the plane of the annulus both toward and away from the center of the valve orifice in a rhythmic pattern that enables the wire to contact both the valve leaflets and the adjacent heart walls, the wire contacting the head walls forming a anchoring member that provides a holding force to the retainer by embedding into adjacent tissue without damaging it. 32. The medical device of claim 31, wherein the wire is manufactured from a super-elastic material. 33. A medical device, comprising: a heart chamber framework having two hoops positioned in approximately parallel planes and connected by vertical struts that are coupled to each hoop. 34. The medical device of claim 33, wherein the medical device is manufactured from a super-elastic material. 35. A medical device comprising: a heart chamber framework having a first hoop and a second hoop, the hoops positioned in parallel planes and connected by vertical struts that are coupled to each hoop, and a neo-leaflet coupled to the first hoop, positioned to supplement or replace a native leaflet. 36. The medical device of claim 35, wherein the framework is manufactured from a super-elastic material. 37. The medical device of claim 35, further comprising a second neo-leaflet coupled to the interior surface of the first hoop, positioned to supplement or replace a native leaflet. 38. A medical device comprising: a leaflet retainer, the leaflet retainer formed of a wire that is shaped to extend over a leaflet and restrict the leaflet's movements upstream of blood flow, and a framework, the framework formed of a wire that is shaped to extend into the upstream heart chamber, and to contact the upstream chamber and transmit force from the chamber to the framework and then to the leaflet retainer, wherein the leaflet retainer and framework are comprised of a continuous wire. 39. The medical device of claim 38, wherein the medical device is manufactured from a super-elastic material. 40. The medical device of claim 38, wherein the device may be deployed from an intravascular catheter device. 41. A medical device comprising: a tulip-shaped wire form, wherein the tulip-shaped wire form has a framework and leaflet retainer, the leaflet retainer formed of a wire that is shaped to extend over one or more leaflets and restrict the leaflets movements upstream of blood flow, and a framework, the framework formed of a wire that is shaped to extend into the upstream heart chamber, and to contact the upstream chamber and transmit force from the chamber to the framework and then to the leaflet retainer, wherein the leaflet retainer and framework are comprised of a continuous wire. 42. The medical device of claim 41, wherein the wire form is manufactured from a super-elastic material. 43. A medical device comprising: a twisted tulip-shaped wire form, wherein the twisted tulip-shaped wire form has a framework and leaflet retainer, the leaflet retainer formed of a wire that is shaped to extend over one or more leaflets and restrict the leaflets movements upstream of normal blood flow, and a framework, the framework formed of a wire that is shaped to extend into the upstream heart chamber, and to contact the upstream chamber and transmit force from the chamber to the framework and then to the leaflet retainer, wherein the leaflet retainer and framework are comprised of a continuous wire. 44. The medical device of claim 43, wherein the wire form is manufactured from a super-elastic material. 45. A medical device comprising: a mesh-shaped wire form, wherein the mesh-shaped wire form has a framework and leaflet retainer, the leaflet retainer formed of a wire that is shaped to extend over one or more leaflets and restrict the leaflets movements upstream of normal blood flow, and a framework, the framework formed of a wire that is shaped to extend into the upstream heart chamber, and to contact the upstream chamber and transmit force from the chamber to the framework and then to the leaflet retainer, wherein the leaflet retainer and framework are comprised of a continuous wire. 46. The medical device of claim 45, wherein the medical device is manufactured from a super-elastic material. 47. A medical device, comprising: a corona-shaped wire form, wherein the corona-shaped wire form is formed of a single wire that radiates between the valve base and the chamber apex and contacts the adjacent chamber walls. 48. The medical device of claim 47, wherein the medical device is manufactured from a super-elastic material. 49. A method for installing medical devices: introducing a guidewire into a patient's blood vessel; advancing the guidewire into the heart; advancing a catheter over the guidewire, the catheter pre-loaded with a medical device comprising: a base member, the base member having a shape that tracks the circumference of a native heart valve annulus; and a bridge member, the bridge member extending from the base member over the heart valve orifice, and supported by the base member; advancing the catheter within the vessel so that the medical device reaches its desired position within the heart; releasing the medical device into the desired location within the heart; positioning the medical device within the desired location of the heart; and withdrawing the catheter from the patient. Description
RELATED APPLICATIONS [0001] This application is a continuation of International Patent Application Serial No. PCT/US02/31376, entitled “Methods and Devices for Heart Valve Treatment”, having an international filing date of Oct. 1, 2002 and a priority date of Oct. 1, 2001, based upon the benefit of U.S. Provisional Patent Application Serial No. 60/326,590, filed Oct. 1, 2001 and entitled “Methods and Systems for Herat Chamber Endocardial and Epicardial Scaffold Therapies.”
FIELD OF THE INVENTION [0002] This invention relates to methods and devices to improve the function of heart valves. More particularly, the invention relates to methods and devices to treat mitral valve regurgitation. BACKGROUND OF THE INVENTION [0003] The opening and closing of heart valves occur primarily as a result of pressure differences. For example, the opening and closing of the mitral valve occurs as a result of the pressure differences between the left atrium and the left ventricle. During ventricular diastole, when ventricles are relaxed, the venous return of blood from the pulmonary veins into the left atrium causes the pressure in the atrium to exceed that in the ventricle. As a result, the mitral valve opens, allowing blood to enter the ventricle. As the ventricle contracts during ventricular systole, the intraventricular pressure rises above the pressure in the atrium and pushes the mitral valve shut. [0004] The high pressure produced by contraction of the ventricle could push the valve leaflets too much and evert them. Prolapse is a term used to describe this condition. This is normally prevented by contraction of the papillary muscles within the ventricle, which are connected to the mitral valve leaflets by the chordae tendineae (chords). Contraction of the papillary muscles is simultaneous with the contraction of the ventricle and serves to keep healthy valve leaflets tightly shut at peak contraction pressures exerted by the ventricle. [0005] Valve malfunction can result from the chords becoming stretched, and in some cases tearing. When a chord tears, the result is a flailed leaflet. Also, a normally structured valve may not function properly because of an enlargement of the valve annulus. This condition is referred to as a dilation of the annulus and generally results from heart muscle failure. In addition, the valve may be defective at birth or because of an acquired disease. SUMMARY OF THE INVENTION [0006] The present invention is a group of medical devices designed to improve heart valve function. The medical devices may be used individually, or in combination to supplement damaged valves, replace damaged valves, or improve damaged valves function. The medical devices include leaflet retainers, a neo-annulus, neo-leaflet, and a framework. In addition, the present invention includes novel methods for surgically treating heart valves. BRIEF DESCRIPTION OF THE DRAWINGS [0007] [0007]FIG. 1 shows a posterior oblique cutaway view of a patient's heart 100. [0008] [0008]FIG. 2 shows a cutaway view of a patient's heart 200 with a prolapsed mitral valve that does not form a tight seal during ventricular systole, and thus allows blood to be regurgitated back into the left atrium during ventricular contraction. [0009] [0009]FIG. 3 shows a cutaway view of a patient's heart 300 with a flailing mitral valve 320 that does not form a tight seal during ventricular systole, and thus allows blood to be regurgitated back into the left atrium during ventricular contraction as indicated by arrows. [0010] [0010]FIG. 4 shows a perspective view of a spring bridge neo-leaflet used to supplement or replace a native leaflet. [0011] [0011]FIG. 5 shows a perspective view of an embodiment of the invention comprised of a bridge 540, spanning material 530, attachment means 550, and a base 520. In addition, the device is shown to have a framework 510. [0012] [0012]FIG. 6 shows a perspective view of the embodiment of FIG. 5 in the open valve position. [0013] [0013]FIG. 7 shows a perspective view of the embodiments shown in FIGS. 5 and 6 positioned within the left atrium of the heart. [0014] [0014]FIGS. 8 and 9 show a perspective view of the embodiments of FIGS. 5 and 6 positioned within the left atrium of the heart. [0015] [0015]FIG. 10 shows a perspective view of an embodiment of the invention having a framework 1010 that avoids the pulmonary veins (not shown). [0016] [0016]FIGS. 11 and 12 show a perspective view of a dual spring bridge neo-leaflet having an anterior bridge spanned by an anterior material 1110, and a posterior bridge spanned by a posterior material 1120. [0017] [0017]FIG. 13 shows a perspective view of a damaged native anterior leaflet 1310 that is not connected to the chordae tendineae. [0018] [0018]FIG. 14 shows a perspective view of a device 1400 having a half sewing ring 1420 with a membrane 1410 that serves as a neo-annulus or a neo-leaflet. [0019] [0019]FIG. 15 shows a perspective view of a device 1500 having a full sewing ring 1530 with a membrane 1510 that serves as a neo-annulus or a neo-leaflet. [0020] [0020]FIG. 16 shows a perspective view of a leaflet retainer 1600 that is positioned within the atrium on top of both native mitral valve leaflets. [0021] [0021]FIG. 17 shows a perspective view of a leaflet retainer 1700 that is positioned within the atrium on top of both native mitral valve leaflets. [0022] [0022]FIG. 18 shows a perspective view of a leaflet retainer 1800 that is positioned within the atrium on top of both native mitral valve leaflets. [0023] [0023]FIG. 19 shows a perspective view of a leaflet retainer 1900 that is positioned on top of both native mitral valve leaflets. [0024] [0024]FIG. 20 shows a side view of the embodiment shown in FIG. 19. [0025] [0025]FIG. 21 shows a perspective view of the embodiment shown in FIG. 19. [0026] [0026]FIGS. 22 through 26 show the sequence of steps for a catheter-based percutaneous deployment of an embodiment of the invention. [0027] [0027]FIG. 27 shows a perspective view of an embodiment of the invention 2700 having a framework that partially fills the atrium. [0028] [0028]FIG. 28 shows a perspective view of an embodiment of the invention 2800 having dual neo-leaflets, 2830 and 2840. [0029] [0029]FIG. 29 shows a perspective view of an embodiment of the invention 2900 having a leaflet retainer 2910 positioned against a native leaflet as well as a framework structure 2920 that meanders about the atrium without interfering with the pulmonary veins. [0030] [0030]FIG. 30 shows a perspective view of another embodiment of the invention 3000 consisting of a continuous wire or tube that forms a leaflet retainer and framework. [0031] [0031]FIG. 31 shows a perspective view of a tulip shaped wire form configuration 3100 of the invention. [0032] [0032]FIG. 32 shows cutaway view of a tulip shaped wire form configuration 3200 of the invention. [0033] [0033]FIG. 33 shows a cutaway view of a tulip with a twist wire form configuration 3300 of the invention. [0034] [0034]FIG. 34 shows a cutaway view of the left atrium and left ventricle. The arrows on the left side of the figure indicate by way of example three different ways in which an embodiment of the invention, such as a leaflet retainer, neo-leaflet, or neo-annulus, may interact with the mitral valve, or be positioned if replacing a leaflet. [0035] [0035]FIG. 35 shows a perspective view of mesh leaflet with buttressing 3500. [0036] [0036]FIG. 36 shows a side view of a corona configuration 3600 of the invention. [0037] [0037]FIG. 37 shows a perspective view of a corona configuration 3700 of the invention in situ within a patient's left atrium. [0038] [0038]FIG. 38 shows a cutaway view of a heart, having both native leaflets, 3810 and 3820, intact. [0039] [0039]FIG. 39 shows a cutaway view of a heart with one embodiment of the invention 3900. [0040] [0040]FIG. 40 shows a cutaway view of a heart with one intact mitral valve leaflet 4010, and one mitral valve leaflet excised, or missing. [0041] [0041]FIG. 41 shows a cutaway view of a heart with one embodiment of the invention 4100. In addition, the shown embodiment has one neo-leaflet 4110. [0042] [0042]FIG. 42 shows a cutaway view of a heart with both mitral valve leaflets removed. [0043] [0043]FIG. 43 shows a cutaway view of a heart with one embodiment of the invention 4300 having two neo-leaflets.
DETAILED DESCRIPTION [0044] [0044]FIG. 1 shows a posterior oblique cutaway view of a patient's heart 100. Two of the four heart chambers are shown, the left atrium 170, and the left ventricle 140 (not shown are the right atrium and right ventricle). The left atrium 170 fills with blood from the pulmonary veins. The blood then passes through the mitral valve (also known as the bicuspid valve, and more generally known as an atrioventricular valve) during ventricular diastole and into the left ventricle 140. During ventricular systole, the blood is then ejected out of the left ventricle 140 through the aortic valve 150 and into the aorta 160. At this time, the mitral valve should be shut so that blood is not regurgitated back into the left atrium. The mitral valve consists of two leaflets, an anterior leaflet 110, and a posterior leaflet 115, attached to chordae tendineae 120 (hereafter, chords), which in turn are connected to papillary muscles 130 within the left atrium 140. Typically, the mitral valve has a D-shaped anterior leaflet 110 oriented toward the aortic valve, with a crescent shaped posterior leaflet 115. The leaflets intersect with the atrium 170 at the mitral annulus 190. [0045] [0045]FIG. 2 shows a cutaway view of a patient's heart 200 with a prolapsed mitral valve that does not form a tight seal during ventricular systole, and thus allows blood to be regurgitated back into the left atrium during ventricular contraction. The anterior 220 and posterior 225 leaflets are shown being blown into the left atrium with arrows indicating the direction of regurgitant flow. Among other causes, regurgitation can result from stretched chords 210 that are too long to prevent the leaflets from being blown into the atrium. As a result, the leaflets do not form a tight seal and blood is regurgitated into the atrium. [0046] [0046]FIG. 3 shows a cutaway view of a patient's heart 300 with a flailing mitral valve 320 that does not form a tight seal during ventricular systole, and thus allows blood to be regurgitated back into the left atrium during ventricular contraction as indicated by arrows. Among other causes, regurgitation can result from torn chords 310. [0047] [0047]FIG. 4 shows a perspective view of a spring bridge neo-leaflet used to supplement or replace a native leaflet. The device 400 is shown to be formed of a base 420 that is positioned around the mitral annulus, and then closes in over the anterior leaflet to form a bridge 430 over the anterior leaflet. The bridge 430 may be a rigid, semi-rigid, or flexible. The bridge may act like a spring, and thus respond dynamically to pressure differentials within the heart. The bridge 430 may have a spanning material 410 that spans the bridge 430. The spanning material 410 may be attached to the device 400 with one or more attachment means 440 (for example, it may be sewn, glued, or welded to the device 400, or it may be attached to itself when wrapped around the device 400). The spanning material 410 maybe made from a synthetic material (for example, thin Nitinol, Dacron fabric, Polytetrafluoroethylene or PTFE, Silicone, or Polyurethane) or a biological material (for example, human or animal pericardium). The device 400 may be delivered percutaneously, through the chest (thoracoscopy), or using open heart surgical techniques. If delivered percutaneously, the device may be made from a super-elastic material (for example, Nitinol) enabling it to be folded and collapsed such that it can be delivered in a catheter, and will subsequently self-expand when released from the catheter. The device may be secured to the mitral annulus with sutures or other attachment means (i.e. barbs, hooks, staples, etc). [0048] [0048]FIG. 5 shows a perspective view of an embodiment of the invention comprised of a bridge 540, spanning material 530, attachment means 550, and a base 520. In addition, the device is shown to have a framework 510. Preferably the framework 510 does not interfere with atrial contractions, instead contracting with the atrium. As such, the device 500 may have non-uniform flexibility to improve its function within the heart. The framework is shown here rising from the base 520 with two substantially parallel arched wires that connect to form a semicircular hoop above the base 520. The framework 510 helps to accurately position the device within the atrium, and also helps to secure the device within the atrium. The neo-leaflet comprised of the bridge 540 and spanning material 530 is shown in the closed valve position. [0049] [0049]FIG. 6 shows a perspective view of the embodiment of FIG. 5 in the open valve position. [0050] [0050]FIG. 7 shows a perspective view of the embodiments shown in FIGS. 5 and 6 positioned within the left atrium of the heart. [0051] [0051]FIGS. 8 and 9 show a perspective view of the embodiments of FIGS. 5 and 6 positioned within the left atrium of the heart. FIG. 8 shows the embodiment in a closed valve position, and FIG. 9 shows the embodiment in an open valve position. The sizing of the base 810 can vary depending upon the patient's needs. [0052] [0052]FIG. 10 shows a perspective view of an embodiment of the invention having a framework 1010 that avoids the pulmonary veins (not shown). [0053] [0053]FIGS. 11 and 12 show a perspective view of a dual spring bridge neo-leaflet have an anterior bridge spanned by an anterior material 1110, and a posterior bridge spanned by a posterior material 1120. The framework 1130 shown here illustrates an alternative design. This embodiment also illustrates a base having clips 1140 that protrude below an imaginary plane formed by the annulus of the valve. FIG. 11 shows the dual neo-leaflets in a closed valve position, and FIG. 12 shows the dual neo-leaflets in an open valve position. [0054] [0054]FIG. 13 shows a perspective view of a damaged native anterior leaflet 1310 that is not connected to the chordae tendineae. [0055] [0055]FIG. 14 shows a perspective view of a device 1400 having a half sewing ring 1420 with a membrane 1410 that serves as a neo-annulus or a neo-leaflet. When serving as a neo-annulus, the membrane 1410 is a relatively immobile structure covering one of the native valve leaflets, particularly a damaged, missing or nonfunctional leaflet. The neo-annulus serves to extend the native annulus and coapts with the remaining functional native leaflet to create a functioning mitral valve. When serving as a neo-leaflet, the membrane 1410 is a mobile structure that moves in response to blood flow, coapting with one of the native leaflets to create a functioning mitral valve. The neo-leaflet replaces the function of a damaged, missing or nonfunctional native leaflet. The device 1400 is attached to the mitral valve annulus via the half sewing ring 1420. This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques. [0056] [0056]FIG. 15 shows a perspective view of a device 1500 having a full sewing ring 1530 with a membrane 1510 that serves as a neo-annulus or a neo-leaflet. The device 1500 has an opening 1520 though the sewing ring 1530 opposite the membrane 1510 for blood flow. Alternatively, this embodiment could have two neo-leaflets. This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques. [0057] [0057]FIG. 16 shows a perspective view of a leaflet retainer 1600 that is positioned within the atrium on top of both native mitral valve leaflets. This embodiment is comprised of an outer ring 1610 and an inner ring 1630 connected by radial struts 1620. The interior region of the valve orifice remains unobstructed to blood flow with this embodiment. This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques. [0058] [0058]FIG. 17 shows a perspective view of a leaflet retainer 1700 that is positioned within the atrium on top of both native mitral valve leaflets. This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques. [0059] [0059]FIG. 18 shows a perspective view of a leaflet retainer 1800 that is positioned within the atrium on top of both native mitral valve leaflets. This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques. [0060] [0060]FIG. 19 shows a perspective view of a leaflet retainer 1900 that is positioned on top of both native mitral valve leaflets. Alternatively, the leaflet retainers may be designed to retain only one leaflet, or a portion of a leaflet, depending on patient needs. The outer sections of this embodiment have anchors 1910 that distribute stresses along the atrial wall, helping to prevent erosion of the atrial walls. This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques. [0061] [0061]FIG. 20 shows a side view of the embodiment shown in FIG. 19. [0062] [0062]FIG. 21 shows a perspective view of the embodiment shown in FIG. 19. [0063] [0063]FIGS. 22 through 26 show the sequence of steps for a catheter-based percutaneous deployment of an embodiment of the invention. This deployment technique applies to other embodiments as well. Initially, a guidewire is introduced into the vasculature via a peripheral venous access site, such as the femoral or jugular vein, or alternatively by means of surgical access through the right atrium. FIG. 22 shows the introduction of a guidewire 2210 through the septum 2220 between the right and left atria. The guidewire is shown being introduced into the right atrium via the inferior vena cava 2230. FIG. 23 shows a catheter 2320 being advanced over the guidewire 2310. FIG. 24 shows an embodiment of the invention 2400 being released from the catheter after the guidewire has been removed. Alternatively, a guidewire could be used to place the device. FIG. 25 shows an embodiment of the invention having an additional feature, a looped eyelet 2500 that is being placed within a pulmonary vein to help position the device within the atrial chamber. The looped eyelet 2500 could be advanced over a guidewire. FIG. 26 shows an embodiment of the invention 2600 being positioned within the left atrium. The device 2600 can be positioned or repositioned within the atrium using a catheter deployed grasping instrument 2610. [0064] [0064]FIG. 27 shows a perspective view of an embodiment of the invention 2700 having a framework that partially fills the atrium. [0065] [0065]FIG. 28 shows a perspective view of an embodiment of the invention 2800 having dual neo-leaflets, 2830 and 2840. The device is comprised of a framework 2810 an annular base 2820, and the neo-leaflets, 2830 and 2840. The neo-leaflets supplement or replace native leaflets, and thus function as a one-way valve to allow blood to flow from the atrium to the ventricle, and to prevent blood from flowing from the ventricle to the atrium. This is accomplished because the neo-leaflets structure is similar to native leaflet structure. [0066] [0066]FIG. 29 shows a perspective view of an embodiment of the invention 2900 having a leaflet retainer 2910 positioned against a native leaflet as well as a framework structure 2920 that meanders about the atrium without interfering with the pulmonary veins. The leaflet retainer 2910 prevents the leaflet from prolapsing into the atrium due to the pressure differential during ventricular contractions, thus improving closure of the mitral valve and reducing regurgitation. [0067] [0067]FIG. 30 shows a perspective view of another embodiment of the invention 3000 consisting of a continuous wire or tube that forms a leaflet retainer and framework. The geometry of the framework is such that it spirals upward within the atrium. The device 3000 is secured in place because the framework expands within the atrium, and experiences mural pressures. The leaflet retainer is secured in place over a native leaflet by its coupling to the framework, and the leaflet retainer functions to prevent the native leaflet from experiencing prolapse. In addition, a coating that promotes tissue growth may aid in the fixation process of the framework within the atrium. However, the leaflet retainer section of the device 3000 may benefit from a coating that inhibits tissue growth, thus allowing the native leaflet to allow blood to flow into the ventricle. [0068] [0068]FIG. 31 shows a perspective view of a tulip shaped wire form configuration 3100 of the invention. [0069] [0069]FIG. 32 shows cutaway view of a tulip shaped wire form configuration 3200 of the invention. The illustration shows the device 3200 making contact with native leaflets, 3220 and 3210, to prevent prolapse. The device 3200 is comprised of a leaflet retainer section that functions to prevent the native leaflets, 3210 and 3220, from being blown into the atrium when the ventricle contracts. The leaflet retaining section is positioned directly over the native leaflets. In this embodiment, the leaflet retaining aspect of the device 3200 is shown to be integrally formed with the framework section of the device. However, in other embodiments, the leaflet retainer and framework may be separate structures which can be deployed separately for individual use or in combination. [0070] [0070]FIG. 33 shows a cutaway view of a tulip with a twist wire form configuration 3300 of the invention. The twist aspect enables the device to be shortened through twisting to decrease the longitudinal spring constant. The device 3300 is comprised of a leaflet retainer section that functions to prevent the native leaflets from being blown into the atrium when the ventricle contracts. The leaflet retaining section is positioned directly over the native leaflets. In this embodiment, the leaflet retaining aspect of the device 3300 is shown to be integrally formed with the framework section of the device. However, in other embodiments, the leaflet retainer and framework may be separate structures which can be deployed separately for individual use or in combination. [0071] [0071]FIG. 34 shows a cutaway view of the left atrium and left ventricle. The arrows on the left side of the figure indicate by way of example three different ways in which an embodiment of the invention, such as a leaflet retainer, neo-leaflet, or neo-annulus, may interact with the mitral valve, or be positioned if replacing a leaflet. In other words, an embodiment of the invention may lie in a plane formed by the annulus of the mitral valve as indicated by the middle arrow 3410. Also, an embodiment of the invention may lie either above or below the plane of the annulus, as indicated by the top 3400 and bottom 3420 arrows, respectively. In addition, FIG. 34 could also be used to illustrate potential movements when these components of the invention are configured as a spring bridge that spans the mitral annulus and actively moves with the valve leaflet(s). A spring bridge may be configured so that it is biased in the open valve position, and is forced shut by increasing pressure within the ventricle. Alternatively, the spring bridge may not be biased open or closed, but simply move in response to pressure differentials. Also, the spring bridge may be biased in the closed position. [0072] [0072]FIG. 35 shows a perspective view of mesh leaflet with buttressing 3500. The embodiment is comprised of a framework 3510 and leaflet retainer 3520. The interior region of the valve orifice 3530 of this embodiment is left open to facilitate the flow of blood between the heart's chambers. The leaflet retainer 3520 prevents native leaflets from being blown into the atrium upon ventricular contraction. The framework 3510 transmits mural pressures to the leaflet retainer, encouraging the leaflet retainer to remain positioned over the native leaflets. [0073] [0073]FIG. 36 shows a side view of a corona configuration 3600 of the invention. This embodiment may be used as a framework, to which a leaflet retainer or other valve enhancing device could be attached or coupled to. [0074] [0074]FIG. 37 shows a perspective view of a corona configuration 3700 of the invention in situ within a patient's left atrium. [0075] [0075]FIG. 38 shows a cutaway view of a heart, having both native leaflets, 3810 and 3820, intact. [0076] [0076]FIG. 39 shows a cutaway view of a heart with one embodiment of the invention 3900. [0077] [0077]FIG. 40 shows a cutaway view of a heart with one intact mitral valve leaflet 4010, and one mitral valve leaflet excised, or missing. The chords 4020 of the removed leaflet are shown disconnected. [0078] [0078]FIG. 41 shows a cutaway view of a heart with one embodiment of the invention 4100. In addition, the shown embodiment has one neo-leaflet 4110. This neo-leaflet 4110 may be rigid, semi-rigid, or flexible. [0079] [0079]FIG. 42 shows a cutaway view of a heart with both mitral valve leaflets removed. The chords 4210 are shown disconnected. [0080] [0080]FIG. 43 shows a cutaway view of a heart with one embodiment of the invention 4300 having two neo-leaflets. [0081] These devices may be delivered to the heart via open heart surgery, through the chest, or through a remote blood vessel. Examples of delivery through a remote blood vessel include the use of guidewires and catheters. They can be advanced into the right atrium through the superior or inferior vena cava (transluminally, via a peripheral venous insertion site, such as the femoral or jugular vein), or into the left ventricle through the aorta. The left atrium can be accessed from the right atrium through the septum. Alternatively, the left atrium can be accessed from the left ventricle through the mitral valve using a transluminal procedure gaining access via a peripheral arterial insertion site, such as the femoral artery. Echo techniques are used to determine whether a patient is experiencing regurgitation, and various imaging techniques can be used to position the device. [0082] The devices shown may be anchored within the left atrium using barbs, staples, adhesives, magnets, etc. In addition, the devices may be coated with various materials to either promote (Dacron) or inhibit (heparin) tissue growth around the devices, to prevent thrombosis, or coated with other desired materials to encourage other desirable characteristics. Anchoring can also be done on the opposite (ventricular) side of the valve. [0083] While the present invention has been described herein with respect to the exemplary embodiments and the best mode for practicing the invention it will become apparent to one of ordinary skill in the art that many modifications, improvements and sub combinations of the various embodiments, adaptations and variations can be made to the invention without departing from the spirit and scope thereof. Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS4056854 *Sep 28, 1976Nov 8, 1977The United States Of America As Represented By The Department Of Health, Education And WelfareAortic heart valve catheterUS4994069 *Nov 2, 1988Feb 19, 1991Target TherapeuticsVaso-occlusion coil and methodUS5370685 *Jul 16, 1991Dec 6, 1994Stanford Surgical Technologies, Inc.Endovascular aortic valve replacementUS5545241 *Jan 17, 1995Aug 13, 1996Donaldson Company, Inc.Air cleanerUS5776189 *Mar 5, 1997Jul 7, 1998Khalid; NaqeebCardiac valvular support prosthesisUS5855601 *Jun 21, 1996Jan 5, 1999The Trustees Of Columbia University In The City Of New YorkArtificial heart valve and method and device for implanting the sameUS6077214 *Jul 29, 1998Jun 20, 2000Myocor, Inc.Stress reduction apparatus and methodUS6102932 *Dec 15, 1998Aug 15, 2000Micrus CorporationIntravascular device push wire delivery systemUS6165119 *Jan 4, 1999Dec 26, 2000Myocor, Inc.Heart wall tension reduction apparatus and methodUS6183411 *Sep 21, 1998Feb 6, 2001Myocor, Inc.External stress reduction device and methodUS6260552 *Jul 29, 1998Jul 17, 2001Myocor, Inc.Transventricular implant tools and devicesUS6312464 *Apr 28, 1999Nov 6, 2001NAVIA JOS� L.Method of implanting a stentless cardiac valve prosthesisUS6332893 *Dec 17, 1997Dec 25, 2001Myocor, Inc.Valve to myocardium tension members device and methodUS6338735 *Mar 15, 1996Jan 15, 2002John H. StevensMethods for removing embolic material in blood flowing through a patient's ascending aortaUS6338740 *Jan 26, 2000Jan 15, 2002Edwards Lifesciences CorporationFlexible heart valve leafletsUS6419695 *May 22, 2000Jul 16, 2002Shlomo GabbayCardiac prosthesis for helping improve operation of a heart valveUS6440164 *Oct 21, 1999Aug 27, 2002Scimed Life Systems, Inc.Implantable prosthetic valveUS6537198 *Mar 21, 2000Mar 25, 2003Myocor, Inc.Splint assembly for improving cardiac function in hearts, and method for implanting the splint assemblyUS6629534 *Apr 7, 2000Oct 7, 2003Evalve, Inc.Methods and apparatus for cardiac valve repairUS6702826 *Jun 22, 2001Mar 9, 2004Viacor, Inc.Automated annular plication for mitral valve repairUS6764510 *Jan 9, 2002Jul 20, 2004Myocor, Inc.Devices and methods for heart valve treatmentUS6913608 *Oct 23, 2001Jul 5, 2005Viacor, Inc.Automated annular plication for mitral valve repairUS6945978 *Nov 15, 2002Sep 20, 2005Advanced Cardiovascular Systems, Inc.Heart valve catheterUS7004176 *Oct 17, 2003Feb 28, 2006Edwards Lifesciences AgHeart valve leaflet locatorUS20020032481 *Oct 9, 2001Mar 14, 2002Shlomo GabbayHeart valve prosthesis and sutureless implantation of a heart valve prosthesisUS20020065554 *Oct 25, 2001May 30, 2002Streeter Richard B.Mitral shieldUS20020129820 *Oct 16, 2001Sep 19, 2002Medtronic, IncAnnuloplasty band and methodUS20030040792 *Oct 8, 2002Feb 27, 2003Shlomo GabbayHeart valve prosthesis and sutureless implantation of a heart valve prosthesisUS20030233022 *Jun 9, 2003Dec 18, 2003Vidlund Robert M.Devices and methods for heart valve treatmentUS20040148019 *Nov 10, 2003Jul 29, 2004Vidlund Robert M.Devices and methods for heart valve treatmentUS20060241745 *Apr 19, 2006Oct 26, 2006Solem Jan OBlood flow controlling apparatus* Cited by examinerReferenced byCiting PatentFiling datePublication dateApplicantTitleUS6997950 *Jan 16, 2003Feb 14, 2006Chawla Surendra KValve repair deviceUS7611534 *Aug 24, 2006Nov 3, 2009The Cleveland Clinic FoundationPercutaneous atrioventricular valve and method of useUS7621948Jul 20, 2004Nov 24, 2009The Trustees Of The University Of PennsylvaniaPercutaneous heart valveUS7655015Dec 21, 2007Feb 2, 2010Evalve, Inc.Fixation devices, systems and methods for engaging tissueUS7658759 *Jul 17, 2006Feb 9, 2010Cook IncorporatedIntralumenally implantable framesUS7666204May 19, 2003Feb 23, 2010Evalve, Inc.Multi-catheter steerable guiding system and methods of useUS7670368Mar 2, 2010Boston Scientific Scimed, Inc.Venous valve apparatus, system, and methodUS7682319Feb 25, 2009Mar 23, 2010Evalve, Inc.Steerable access sheath and methods of useUS7682369Feb 14, 2006Mar 23, 2010Evalve, Inc.Surgical device for connecting soft tissueUS7682385Jul 3, 2006Mar 23, 2010Boston Scientific CorporationArtificial valveUS7704269Aug 5, 2003Apr 27, 2010Evalve, Inc.Methods and apparatus for cardiac valve repairUS7704277Sep 14, 2005Apr 27, 2010Edwards Lifesciences AgDevice and method for treatment of heart valve regurgitationUS7722666Apr 15, 2005May 25, 2010Boston Scientific Scimed, Inc.Valve apparatus, system and methodUS7731649Mar 28, 2001Jun 8, 2010Cube S.R.L.Endoventicular device for the treatment and correction of cardiomyopathiesUS7736388Jan 16, 2007Jun 15, 2010Evalve, Inc.Fixation devices, systems and methods for engaging tissueUS7753923Aug 25, 2004Jul 13, 2010Evalve, Inc.Leaflet suturingUS7753949Oct 10, 2007Jul 13, 2010The Trustees Of The University Of PennsylvaniaValve prosthesis systems and methodsUS7758596Oct 15, 2002Jul 20, 2010The Trustees Of Columbia University In The City Of New YorkMethod and apparatus for circulatory valve repairUS7776053Dec 12, 2006Aug 17, 2010Boston Scientific Scimed, Inc.Implantable valve systemUS7780627Jul 16, 2007Aug 24, 2010Boston Scientific Scimed, Inc.Valve treatment catheter and methodsUS7780722Feb 7, 2005Aug 24, 2010Boston Scientific Scimed, Inc.Venous valve apparatus, system, and methodUS7799038Jan 20, 2006Sep 21, 2010Boston Scientific Scimed, Inc.Translumenal apparatus, system, and methodUS7811296Oct 27, 2004Oct 12, 2010Evalve, Inc.Fixation devices for variation in engagement of tissueUS7854755Feb 1, 2005Dec 21, 2010Boston Scientific Scimed, Inc.Vascular catheter, system, and methodUS7854761Dec 19, 2003Dec 21, 2010Boston Scientific Scimed, Inc.Methods for venous valve replacement with a catheterUS7867274Feb 23, 2005Jan 11, 2011Boston Scientific Scimed, Inc.Valve apparatus, system and methodUS7878966Feb 4, 2005Feb 1, 2011Boston Scientific Scimed, Inc.Ventricular assist and support deviceUS7892276Dec 21, 2007Feb 22, 2011Boston Scientific Scimed, Inc.Valve with delayed leaflet deploymentUS7938827Mar 10, 2009May 10, 2011Evalva, Inc.Cardiac valve leaflet attachment device and methods thereofUS7942927Mar 9, 2005May 17, 2011Baker Medical Research InstituteTreating valve failureUS7951189Jul 27, 2009May 31, 2011Boston Scientific Scimed, Inc.Venous valve, system, and method with sinus pocketUS7967853Feb 5, 2008Jun 28, 2011Boston Scientific Scimed, Inc.Percutaneous valve, system and methodUS7981123Feb 3, 2010Jul 19, 2011Evalve, Inc.Surgical device for connecting soft tissueUS7988725Jun 15, 2009Aug 2, 2011Valtech Cardio, Ltd.Segmented ring placementUS7998151Aug 25, 2004Aug 16, 2011Evalve, Inc.Leaflet suturingUS8002824Jul 23, 2009Aug 23, 2011Boston Scientific Scimed, Inc.Cardiac valve, system, and methodUS8012198Sep 6, 2011Boston Scientific Scimed, Inc.Venous valve, system, and methodUS8029518Oct 30, 2007Oct 4, 2011Evalve, Inc.Methods and devices for capturing and fixing leaflets in valve repairUS8052592Oct 7, 2009Nov 8, 2011Evalve, Inc.Methods and devices for tissue grasping and assessmentUS8052751Jul 2, 2004Nov 8, 2011Flexcor, Inc.Annuloplasty rings for repairing cardiac valvesUS8057493Dec 18, 2009Nov 15, 2011Evalve, Inc.Fixation devices, systems and methods for engaging tissueUS8070802Feb 8, 2008Dec 6, 2011The Trustees Of The University Of PennsylvaniaMitral valve systemUS8118866Oct 21, 2009Feb 21, 2012The Trustees Of The University Of PennsylvaniaMethod for heart valve implantationUS8123703Feb 3, 2010Feb 28, 2012Evalve, Inc.Steerable access sheath and methods of useUS8128681Dec 19, 2003Mar 6, 2012Boston Scientific Scimed, Inc.Venous valve apparatus, system, and methodUS8128691Sep 5, 2006Mar 6, 2012Medtentia International Ltd. OyDevice and method for improving the function of a heart valveUS8133270Jan 8, 2008Mar 13, 2012California Institute Of TechnologyIn-situ formation of a valveUS8137394Jan 14, 2011Mar 20, 2012Boston Scientific Scimed, Inc.Valve with delayed leaflet deploymentUS8187299Oct 29, 2007May 29, 2012Evalve, Inc.Methods and apparatus for cardiac valve repairUS8216230Apr 4, 2011Jul 10, 2012Evalve, Inc.Cardiac valve leaflet attachment device and methods thereofUS8216256Feb 26, 2009Jul 10, 2012Evalve, Inc.Detachment mechanism for implantable fixation devicesUS8216303 *Nov 19, 2008Jul 10, 2012The Cleveland Clinic FoundationApparatus and method for treating a regurgitant heart valveUS8262725Apr 16, 2008Sep 11, 2012Cardiovascular Technologies, LlcTransvalvular intraannular band for valve repairUS8323334Jan 28, 2009Dec 4, 2012Evalve, Inc.Methods and apparatus for cardiac valve repairUS8337390Jul 30, 2008Dec 25, 2012Cube S.R.L.Intracardiac device for restoring the functional elasticity of the cardiac structures, holding tool for the intracardiac device, and method for implantation of the intracardiac device in the heartUS8337524May 11, 2010Dec 25, 2012Kardium Inc.Method and device for closing holes in tissueUS8343174Sep 4, 2009Jan 1, 2013Evalve, Inc.Locking mechanisms for fixation devices and methods of engaging tissueUS8348999Feb 13, 2012Jan 8, 2013California Institute Of TechnologyIn-situ formation of a valveUS8409273Oct 30, 2007Apr 2, 2013Abbott Vascular IncMulti-catheter steerable guiding system and methods of useUS8414641Mar 2, 2012Apr 9, 2013Boston Scientific Scimed, Inc.Valve with delayed leaflet deploymentUS8460365May 27, 2011Jun 11, 2013Boston Scientific Scimed, Inc.Venous valve, system, and method with sinus pocketUS8460370Apr 15, 2010Jun 11, 2013Edwards Lifesciences AgDevice and method for treatment of heart valve regurgitationUS8470023Jun 22, 2011Jun 25, 2013Boston Scientific Scimed, Inc.Percutaneous valve, system, and methodUS8470027Feb 27, 2006Jun 25, 2013Medtentia International Ltd. OyDevices and a kit for improving the function of a heart valveUS8470028Jan 19, 2010Jun 25, 2013Evalve, Inc.Methods, systems and devices for cardiac valve repairUS8480732Nov 25, 2009Jul 9, 2013Heart Repair Technologies, Inc.Transvalvular intraannular band for valve repairUS8500761Dec 11, 2009Aug 6, 2013Abbott VascularFixation devices, systems and methods for engaging tissueUS8512399Dec 28, 2009Aug 20, 2013Boston Scientific Scimed, Inc.Valve apparatus, system and methodUS8597226Jun 12, 2012Dec 3, 2013Jenavalve Technology, Inc.Methods and conduits for flowing blood from a heart chamber to a blood vesselUS8608797Mar 15, 2006Dec 17, 2013Valtech Cardio Ltd.Mitral valve treatment techniquesUS8622884Apr 27, 2010Jan 7, 2014Cube S.R.L.Endoventicular device for the treatment and correction of cardiomyopathiesUS8672997Apr 24, 2012Mar 18, 2014Boston Scientific Scimed, Inc.Valve with sinusUS8672998Apr 29, 2013Mar 18, 2014Kardium Inc.Method for anchoring a mitral valveUS8721717Jan 27, 2012May 13, 2014Boston Scientific Scimed, Inc.Venous valve apparatus, system, and methodUS8734505Sep 24, 2009May 27, 2014Evalve, Inc.Methods and apparatus for cardiac valve repairUS8740918Jun 9, 2011Jun 3, 2014Evalve, Inc.Surgical device for connecting soft tissueUS8740920May 22, 2013Jun 3, 2014Evalve, Inc.Fixation devices, systems and methods for engaging tissueUS8758430Jan 23, 2009Jun 24, 2014Jenavalve Technology, Inc.Medical apparatus for the therapeutic treatment of an insufficient cardiac valveUS8784483Jan 4, 2012Jul 22, 2014The Cleveland Clinic FoundationApparatus and method for treating a regurgitant heart valveUS8828079Jul 26, 2007Sep 9, 2014Boston Scientific Scimed, Inc.Circulatory valve, system and methodUS8926695Dec 5, 2007Jan 6, 2015Valtech Cardio, Ltd.Segmented ring placementUS8932348May 17, 2007Jan 13, 2015Edwards Lifesciences CorporationDevice and method for improving heart valve functionUS8932349Aug 22, 2011Jan 13, 2015Boston Scientific Scimed, Inc.Cardiac valve, system, and methodUS8940002Sep 28, 2011Jan 27, 2015Kardium Inc.Tissue anchor systemUS8940044Jun 23, 2011Jan 27, 2015Valtech Cardio, Ltd.Closure element for use with an annuloplasty structureUS8956406Sep 28, 2012Feb 17, 2015Heart Repair Technologies, Inc.Transvalvular intraanular band and chordae cutting for ischemic and dilated cardiomyopathyUS8968395Apr 4, 2012Mar 3, 2015Edwards Lifesciences CorporationProsthetic insert for treating a mitral valveUS8992605Jun 5, 2013Mar 31, 2015Edwards Lifesciences AgDevice and method for reducing mitral valve regurgitationUS9011530Jun 23, 2011Apr 21, 2015Valtech Cardio, Ltd.Partially-adjustable annuloplasty structureUS9028542Sep 6, 2011May 12, 2015Boston Scientific Scimed, Inc.Venous valve, system, and methodUS9044246Aug 24, 2011Jun 2, 2015Abbott Vascular Inc.Methods and devices for capturing and fixing leaflets in valve repairUS9050066May 20, 2011Jun 9, 2015Kardium Inc.Closing openings in anatomical tissueUS9056009 *Jun 15, 2012Jun 16, 2015Medtentia International Ltd. OyDevice and method for improving function of heart valveUS9060858May 28, 2013Jun 23, 2015Evalve, Inc.Methods, systems and devices for cardiac valve repairUS9072511Mar 15, 2012Jul 7, 2015Kardium Inc.Medical kit for constricting tissue or a bodily orifice, for example, a mitral valveUS9155620Jun 15, 2009Oct 13, 2015Valtec Cardio, Ltd.Annuloplasty devices and methods of delivery thereforUS9173737 *Apr 23, 2009Nov 3, 2015Medtronic, Inc.Stented heart valve devicesUS9180006Feb 27, 2006Nov 10, 2015Medtentia AbDevices and a kit for improving the function of a heart valveUS9192468Jan 23, 2014Nov 24, 2015Kardium Inc.Method for anchoring a mitral valveUS9192472Jun 15, 2009Nov 24, 2015Valtec Cardio, Ltd.Annuloplasty devices and methods of delivery thereforUS9204964Jun 13, 2013Dec 8, 2015Kardium Inc.Medical device, kit and method for constricting tissue or a bodily orifice, for example, a mitral valveUS20030158570 *Mar 28, 2001Aug 21, 2003Paolo FerrazziEndoventicular device for the treatment and correction of cardiomyopathiesUS20030201519 *Apr 10, 2003Oct 30, 2003Lamson Michael A.Semiconductor package with conductor impedance selected during assemblyUS20040002719 *Oct 15, 2002Jan 1, 2004Oz Mehmet C.Method and apparatus for circulatory valve repairUS20040143323 *Jan 16, 2003Jul 22, 2004Chawla Surenda K.Valve repair deviceUS20040199183 *Apr 28, 2004Oct 7, 2004Oz Mehmet C.Method and apparatus for circulatory valve repairUS20050004668 *Jul 2, 2004Jan 6, 2005Flexcor, Inc.Annuloplasty rings and methods for repairing cardiac valvesUS20050033446 *Apr 7, 2004Feb 10, 2005Evalve, Inc. A California CorporationMethods and apparatus for cardiac valve repairUS20050107871 *Mar 30, 2004May 19, 2005Fidel RealyvasquezApparatus and methods for valve repairUS20050149014 *Feb 15, 2005Jul 7, 2005Quantumcor, Inc.Cardiac valve leaflet attachment device and methods thereofUS20060058871 *Sep 14, 2005Mar 16, 2006Edwards Lifesciences, AgDevice and method for treatment of heart valve regurgitationUS20060241745 *Apr 19, 2006Oct 26, 2006Solem Jan OBlood flow controlling apparatusUS20060259135 *Apr 20, 2006Nov 16, 2006The Cleveland Clinic FoundationApparatus and method for replacing a cardiac valveUS20070016286 *Jul 20, 2004Jan 18, 2007Herrmann Howard CPercutaneous heart valveUS20070021826 *Jul 17, 2006Jan 25, 2007Cook IncorporatedIntralumenally implantable framesUS20070156233 *Aug 24, 2006Jul 5, 2007The Cleveland Clinic FoundationPercutaneous atrioventricular valve and method of useUS20070282429 *May 31, 2007Dec 6, 2007Hauser David LProsthetic insert for improving heart valve functionUS20080033541 *Aug 2, 2006Feb 7, 2008Daniel GelbartArtificial mitral valveUS20080208330 *Feb 27, 2006Aug 28, 2008Olli KeranenDevices and a Kit for Improving the Function of a Heart ValveUS20080208332 *Oct 10, 2007Aug 28, 2008Endovalve, Inc.Valve Prosthesis Systems and MethodsUS20080221672 *Feb 8, 2008Sep 11, 2008Endovalve, Inc.Mitral Valve SystemUS20080288060 *Jul 6, 2005Nov 20, 2008Baker Medical Research InstituteTreating Valvular InsufficiencyUS20090043381 *Oct 5, 2005Feb 12, 2009Macoviak John AAtrioventricular valve annulus repair systems and methods including retro-chordal anchorsUS20090132036 *Nov 19, 2008May 21, 2009The Cleveland Clinic FoundationApparatus and method for treating a regurgitant heart valveUS20090149872 *Mar 15, 2006Jun 11, 2009Amir GrossMitral valve treatment techniquesUS20090259307 *Jun 15, 2009Oct 15, 2009Valtech Cardio, Ltd.Segmented ring placementUS20090264995 *Apr 16, 2008Oct 22, 2009Subramanian Valavanur ATransvalvular intraannular band for valve repairUS20100030014 *Jul 30, 2008Feb 4, 2010Cube S.R.L.Intracardiac device for restoring the functional elasticity of the cardiac structures, holding tool for the intracardiac device, and method for implantation of the intracardiac device in the heartUS20100036479 *Apr 23, 2009Feb 11, 2010Medtronic, Inc.Stented Heart Valve DevicesUS20100042208 *Feb 18, 2010The Trustees Of The University Of PennsylvaniaPercutaneous Heart ValveUS20100076550 *Nov 25, 2009Mar 25, 2010Cardiovascular Technologies, LlcTransvalvular intraannular band for valve repairUS20100121435 *Oct 14, 2009May 13, 2010Cardiovascular Technologies, LlcPercutaneous transvalvular intrannular band for mitral valve repairUS20100121437 *Oct 14, 2009May 13, 2010Cardiovascular Technologies, LlcTransvalvular intraannular band and chordae cutting for ischemic and dilated cardiomyopathyUS20100131057 *Oct 14, 2009May 27, 2010Cardiovascular Technologies, LlcTransvalvular intraannular band for aortic valve repairUS20100198347 *Aug 5, 2010Edwards Lifesciences AgDevice and method for treatment of heart valve regurgitationUS20100318183 *Aug 4, 2010Dec 16, 2010Keraenen OlliSystem For Improving The Function Of A Heart ValveUS20100318880 *Aug 4, 2010Dec 16, 2010In Hwan ChoiDtv transmitter and method of coding main and enhanced data in dtv transmitterUS20110066235 *Mar 17, 2011Cube S.R.L.Endoventicular device for the treatment and correction of cardiomyopathiesUS20110319990 *Dec 29, 2011Mvrx, Inc.Devices, systems, and methods for supplementing, repairing or replacing a native heart valve leafletUS20120316640 *Jun 15, 2012Dec 13, 2012Keraenen OlliDevice And Method For Improving Function Of Heart ValveEP1874217A2 *Apr 25, 2006Jan 9, 2008Evalve, Inc.Device and methods for endoscopic annuloplastyEP2478868A1Jan 25, 2011Jul 25, 2012The Provost, Fellows, Foundation Scholars, and the other Members of Board, of the College of the Holy and Undivided Trinity of Queen ElizabethImplant deviceWO2006041877A2 *Oct 5, 2005Apr 20, 2006Ample Medical IncAtrioventricular valve annulus repair systems and methods including retro-chordal anchorsWO2006091163A1 *Feb 27, 2006Aug 31, 2006Medtentia AbDevices and a kit for improving the function of a heart valveWO2006116558A2 *Apr 25, 2006Nov 2, 2006Evalve IncDevice and methods for endoscopic annuloplastyWO2008068756A2Dec 5, 2007Jun 12, 2008Valtech Cardio LtdSegmented ring placementWO2010070649A1Dec 21, 2009Jun 24, 2010Mor Research Applications Ltd.Elongated body for deployment in a coronary sinusWO2011033508A1Sep 15, 2010Mar 24, 2011Transcardia Ltd.Heart valve remodelingWO2012101190A1Jan 25, 2012Aug 2, 2012National University Of Ireland, GalwayImplant device* Cited by examinerClassifications U.S. Classification623/2.36, 623/2.14, 623/23.7International ClassificationA61F2/24, A61F2/06, A61B17/32, A61B19/00, A61B17/22, A61B17/00, A61F2/00, A61B18/14Cooperative ClassificationY10S623/904, A61F2/2466, A61B17/22012, A61B19/26, A61B2017/22097, A61B2017/00247, A61F2/2445, A61B2017/320052, A61B2018/00392, A61F2/2454, A61F2/2412, A61B2017/00243, A61B18/1492, A61B19/00European ClassificationA61F2/24R2, A61F2/24R6, A61B19/26, A61F2/24DLegal EventsDateCodeEventDescriptionDec 5, 2003ASAssignmentOwner name: AMPLE MEDICAL, INC., CALIFORNIAFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RAHDERT, DAVID A.;MACOVIAK, JOHN A.;MACHOLD, TIMOTHY R.;AND OTHERS;REEL/FRAME:014759/0215Effective date: 20031106Jan 7, 2005ASAssignmentOwner name: VENTURE LENDING & LEASING IV, INC., CALIFORNIAFree format text: SECURITY INTEREST;ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:016127/0400Effective date: 20041217Apr 11, 2008ASAssignmentDec 18, 2009ASAssignmentOwner name: VENTURE LENDING & LEASING IV, INC.,CALIFORNIAFree format text: PATENT TRANSFER STATEMENT (UNDER UNIFORM COMMERCIAL CODE SECTION 9-619);ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:023699/0672Effective date: 20091130Owner name: VENTURE LENDING & LEASING V, INC.,CALIFORNIAFree format text: PATENT TRANSFER STATEMENT (UNDER UNIFORM COMMERCIAL CODE SECTION 9-619);ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:023699/0672Effective date: 20091130Jan 29, 2010ASAssignmentOwner name: MVRX, INC.,CALIFORNIAFree format text: BILL OF SALE;ASSIGNORS:VENTURE LENDING & LEASING IV, INC.;VENTURE LENDING & LEASING V, INC.;REEL/FRAME:023882/0030Effective date: 20091130Owner name: MVRX, INC., CALIFORNIAFree format text: BILL OF SALE;ASSIGNORS:VENTURE LENDING & LEASING IV, INC.;VENTURE LENDING & LEASING V, INC.;REEL/FRAME:023882/0030Effective date: 20091130Feb 15, 2010ASAssignmentOwner name: MVRX, INC.,CALIFORNIAFree format text: BILL OF SALE;ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:023928/0968Effective date: 20091130Owner name: MVRX, INC., CALIFORNIAFree format text: BILL OF SALE;ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:023928/0968Effective date: 20091130Jun 13, 2011REMIMaintenance fee reminder mailedNov 7, 2011SULPSurcharge for late paymentNov 7, 2011FPAYFee paymentYear of fee payment: 4May 4, 2015FPAYFee paymentYear of fee payment: 8RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services